HyunseokKangMDMPH, FACP

Endocrine Cancer, Head & Neck Cancer

Professor of Clinical Medicine, University of California San Francisco

Dr. Kang is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
Helen Diller Family Comprehensive Cancer Center
1825 4th Street
San Francisco, CA 94158
Phone+1 415-885-7356

Fax+1 415-333-7984

Emory University School of MedicineFellowship, Hematology and Medical Oncology, 2010 - 2013
Icahn School of Medicine at Mount Sinai/Morningside/WestResidency, Internal Medicine, 2007 - 2010
Yonsei University College of MedicineClass of 2002

Fellow (FACP) American College of Physicians, 2015
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014

PubMed

616 citations
Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non–Small Cell Lung Cancer
Valsamo Anagnostou, Kellie N. Smith, Patrick M. Forde, Noushin Niknafs, Rohit Bhattacharya
Cancer Discovery. 2017-03-01
19 citations
Squamous cell carcinoma of head and neck: what internists should know
Kyungsuk Jung, Manpreet Narwal, Seon Young Min, Bhumsuk Keam, Hyunseok Kang
The Korean Journal of Internal Medicine. 2020-07-14
76 citations
Salivary Secretory Carcinoma With a Novel ETV6-MET Fusion: Expanding the Molecular Spectrum of a Recently Described Entity.
Lisa M. Rooper, Theodoros Karantanos, Yi Ning, Justin A. Bishop, Sarah W. Gordon
The American Journal of Surgical Pathology. 2018-08-01

Journal Articles

Exceptional Responses to Pertuzumab, Trastuzumab, and Docetaxel in Human Epidermal Growth Factor Receptor‐2 High Expressing Salivary Duct Carcinomas
Lisa Rooper, Robert D Foss, Hyunseok Kang, Rishi Sawhney, Nicole C Schmitt, Head & Neck
Pattern of Planned Systemic Therapy Usage in Newly Diagnosed, Nonmetastatic Squamous Cell Carcinoma of the Head and Neck in a Commercially Insured Population in the Un...
Christine G Gourin, Ranee Mehra, Hyunseok Kang, Arlene A Forastiere, Ana P Kiess, Head & Neck
Clinical Benefit to an Aurora A Kinase Inhibitor in a Patient with Metastatic Integrase Interactor 1‐Deficient Carcinoma
Josh Lauring, Lisa Rooper, Sarah Sagorsky, Hyunseok Kang, The Oncologist

FDA Approves Pembrolizumab for Head and Neck CancerAugust 24th, 2016
Rivoceranib Elicits Promising Responses in Adenoid Cystic CarcinomaDecember 15th, 2022

Chair, Oral, Head and Neck Site Committee, UCSF Helen Diller Comprehensive Comprehensive Cancer Center 2024 - Present
Member, Protocol Review Committee, UCSF Helen Diller Family Comprehensive Cancer Center 2022 - Present
Member, Membership Committee, Society for Immunotherapy of Cancer 2019 - Present
Co-director of Oncology Grand Rounds, Educational Committee, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2015 - 2018
Member, Safety Monitoring Committee, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2015 - 2018